検索ワード: clottable (英語 - エストニア語)

clottable protein.
kalgenev proteiin.

(iii) clottable protein.
iii) kalgenev proteiin.

human clottable protein 50 – 90 mg/ ml
koostisaine 1: hüübimist soodustav inimvalk 50… 90 mg/ ml.

evicel human clottable protein / human thrombin
evicel hüübiv inimvalk / inimtrombiin

human clottable protein containing mainly fibrinogen and fibronectin *
hüübimist soodustav inimvalk, mis sisaldab peamiselt fibrinogeeni ja fibronektiini

component 1: human clottable protein 50 – 90 mg/ml
koostisaine 1: hüübimist soodustav inimvalk 50…90 mg/ml.

human clottable protein containing mainly fibrinogen and fibronectin * component 2
hüübimist soodustav inimvalk, mis sisaldab peamiselt fibrinogeeni ja fibronektiini * koostisaine 2

not less than 50 % of the total protein shall be clottable by thrombin.
vähemalt 50 % koguproteiinist peab trombiini mõjul kalgenema.

fibrinogen is a concentrate of clottable protein and thrombin is an enzyme that causes clottable protein to coalesce.
fibrinogeen on hüübiva valgu kontsentraat ja trombiin on ensüüm, mis kutsub esile hüübiva valgu kokkukleepumise.

the human clottable protein contains as its main component, fibrinogen, a protein involved in the natural clotting process.
hüübiv inimvalk sisaldab põhikomponendina fibrinogeeni, mis on vere looduslikus hüübimisprotsessis osalev valk.

evicel must not be used in people who are hypersensitive (allergic) to human clottable protein, thrombin or any of the other ingredients.
eviceli ei tohi kasutada patsiendid, kes on hüübiva inimvalgu, trombiini või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).

the active substances in evicel, human clottable protein and thrombin, are natural substances obtained from human plasma (the liquid part of the blood).
eviceli toimeained hüübiv inimvalk ja trombiin on inimplasmast (vedel verekomponent) saadud looduslikud ained.

it is available as two solutions, one containing the active substance human clottable protein (50 to 90 mg/ml), and the other containing the active substance human thrombin (800 to 1200 international units per millilitre).
ravimit turustatakse kahe lahusena: ühe toimeaine on hüübiv inimvalk (50–90 mg/ml) ja teise toimeaine on inimtrombiin (800–1200 iu/ml).